Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL ANTI-CCR8 ANTIBODIES FOR DETECTING CCR8
Document Type and Number:
WIPO Patent Application WO/2023/219147
Kind Code:
A1
Abstract:
Provided are novel anti-CCR8 antibodies. Said antibodies detect CCR8 expressed in tumor invasive Treg cells or the like and are useful for cancer diagnosis or companion diagnostics.

Inventors:
YOSHIDA TETSUYA (JP)
YOSHIKAWA MAI (JP)
NAGIRA MORIO (JP)
HIRATA MICHINARI (JP)
SHINONOME SATOMI (JP)
UEYAMA AZUMI (JP)
MATSUMOTO REIMI (JP)
TANAKA HIDEKAZU (JP)
OHKURA NAGANARI (JP)
SAKAGUCHI SHIMON (JP)
WADA HISASHI (JP)
Application Number:
PCT/JP2023/017821
Publication Date:
November 16, 2023
Filing Date:
May 12, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHIONOGI & CO (JP)
UNIV OSAKA (JP)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C12N15/13; C12N15/63; G01N33/574; C12P21/08
Domestic Patent References:
WO2020138489A12020-07-02
WO2018181064A12018-10-04
Foreign References:
JP2020511932A2020-04-23
JP2020511937A2020-04-23
JP2001523446A2001-11-27
Other References:
SUZUKI HIROYUKI, SAITO MASAKI, ASANO TEIZO, TANAKA TOMOHIRO, KITAMURA KAISHI, KUDO YUMA, KANEKO MIKA K., KATO YUKINARI: "C 8 Mab-3: An Anti-Mouse CCR8 Monoclonal Antibody for Immunocytochemistry", MONOCLONAL ANTIBODIES IN IMMUNODIAGNOSIS AND IMMUNOTHERAPY, MARY ANN LIEBERT, INC. PUBLISHERS, US, vol. 41, no. 2, 1 April 2022 (2022-04-01), US , pages 110 - 114, XP093109349, ISSN: 2167-9436, DOI: 10.1089/mab.2022.0002
Attorney, Agent or Firm:
YAMAO Norihito et al. (JP)
Download PDF: